Skip to main content

Advertisement

SpringerLink
Log in

A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

This study aims to investigate the prognostic value of the ratio of hemoglobin–RDW (HRR) at diagnosis, in terms of overall survival (OS) and progression-free survival in patients with advanced non-small cell lung cancer (NSCLC).

Methods

Patients with metastatic NCCLC who attended two separate medical oncology clinics between April 2013 and December 2017 were retrospectively screened. HRR was calculated as Hgb (g/dL) divided by the RDW (%). Patients were assigned to either the low HRR group or high HRR group.

Results

A total of 153 patients were included in the study. The cuff-value for HRR was taken as 0.88. Among the low and high HRR groups, Glasgow prognostic scores (GPS), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and weight loss were statistically significantly different (p < 0.05). OS was found to be 5.6 months in the low HRR group and 13.9 months in the high HRR group (p < 0.001) while PFS was 5.1 months and 8.6 months in these two groups, respectively (p < 0.001). Univariate and multivariate analyses revealed that low HRR was an independent factor, predictive of both OS (p = 0.03, Hazard Ratio (HR) = 1.607, 95% CI = 1.041–2.480) and PFS (p < 0.001, HR = 2.635, 95% CI = 1.667–4.166) in advanced NSCLC.

Conclusion

This is the first study to show that low HRR is associated with poor OS and PFS in patients with advanced NSCLC. Thus, hemoglobin and RDW which can be easily measured in routine practice may be used as a prognostic tool in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386

    Article  CAS  Google Scholar 

  2. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics. CA Cancer J Clin 65:5–29. https://doi.org/10.3322/caac.21254

    Article  Google Scholar 

  3. Hoang T, Xu R, Schiller JH et al (2005) Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data. J Clin Oncol 23:175–183

    Article  CAS  PubMed  Google Scholar 

  4. Yin Y, Wang J, Wan X et al (2015) Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: a meta-analysis. Clinics (Sao Paulo) 70(7):524–530

    Article  Google Scholar 

  5. Toda M, Tsukioka T, Izumi N et al (2018) Platelet-to-lymphocyte ratio predicts the prognosis of patients with non-small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy. Thorac Cancer 9(1):112–119

    Article  CAS  PubMed  Google Scholar 

  6. Watanabe K, Yasumoto A, Amano Y et al (2018) Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor. PLoS One 13(9):e0203625

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Holgersson G, Sandelin M, Hoye E E et al (2012) Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. Med Oncol 29(5):3176–3182

    Article  PubMed  Google Scholar 

  8. Ray-Coquard I, Morère JF, Scotté F et al (2012) Management of anemia in advanced breast and lung cancer patients in daily practice: results of a French survey. Adv Ther 29(2):124–133

    Article  CAS  PubMed  Google Scholar 

  9. Vannella L, Lahner E, Osborn J et al (2013) Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 37(4):375–382

    Article  CAS  PubMed  Google Scholar 

  10. Altman AD, Liu XQ, Nelson G et al (2013) The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer. Int J Gynecol Cancer 23(9):1569–1576

    Article  PubMed  Google Scholar 

  11. Fyles AW, Milosevic M, Pintilie M et al (2000) Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 57:13–19

    Article  CAS  PubMed  Google Scholar 

  12. Aoe K, Hiraki A, Maeda T et al (2005) Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer. Intern Med 44(8):800–804

    Article  PubMed  Google Scholar 

  13. Gauthier I, Ding K, Winton T et al (2007) Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR. 10 trial experince. Lung Cancer 55(3):357–363

    Article  CAS  PubMed  Google Scholar 

  14. Zhang YH, Lu Y, Lu H et al (2018) Pretreatment hemoglobin level ıs an ındependent prognostic factor in patients with lung Adenocarcinoma. Can Respir J 15:6328127

    Google Scholar 

  15. Tonelli M, Sacks F, Arnold M et al (2008) Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117(2):163–168

    Article  PubMed  Google Scholar 

  16. Çetinkaya E, Şenol K, Saylam B et al (2014) Red cell distribution width to platelet ratio: new and promising prognostic marker in acute pancreatitis. World J Gastroenterol 20:14450–14454

    Article  PubMed  PubMed Central  Google Scholar 

  17. Xu WS, Qiu XM, Qs O et al (2015) Red blood cell distribution width levels correlate with liver fibrosis and inflammation: a noninvasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis B. Medicine (Baltimore) 94:e612

    Article  CAS  Google Scholar 

  18. Warwick R, Mediratta N, Shackcloth M et al (2014) Preoperative red cell distribution width in patients undergoing pulmonary resections for non-small-cell lung cancer. Eur J Cardiothorac Surg 45(1):108–113

    Article  PubMed  Google Scholar 

  19. Seretis C, Seretis F, Lagoudianakis E et al (2013) Is red cell distribution width a novel biomarker of breast cancer activity? Data from a pilot study. J Clin Med Res 5(2):121

    PubMed  PubMed Central  Google Scholar 

  20. Wang F-M, Xu G, Zhang Y et al (2014) Red cell distribution width is associated with presence, stage, and grade in patients with renal cell carcinoma. Dis Markers 2014:860419

    PubMed  PubMed Central  Google Scholar 

  21. Sun P, Zhang F, Chen C et al (2016) The ratio of hemoglobin tor ed cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China. Oncotarget 7(27):52650–42660

    Google Scholar 

  22. Tham T, Olson C, Wotman M et al (2018) Evaluation of the prognostic utility of the hemoglobin-to- red cell distribution width ratio in head and neck cancer. Eur Arch Otorhinolaryngol 275(11):2869–2878

    Article  PubMed  Google Scholar 

  23. Jin J, Hu K, Zhou Y et al (2017) Clinical utility of the modified Glasgow prognostic score in lung cancer: a meta-analysis. PLoS One 12(9):e0184412

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Felker GM, Allen LA, Pocock SJ et al (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM program and the duke databank. J Am Coll Cardiol 50(1):40–47

    Article  PubMed  Google Scholar 

  25. Kim J, Kim YD, Song TJ et al (2012) Red blood cell distribution width is associated with poor clinical outcome in acute cerebral infarction. Thromb Haemost 108(2):349–356

    Article  CAS  PubMed  Google Scholar 

  26. Seyhan EC, Özgül MA, Tutar N et al (2013) Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. COPD 10(4):416–424

    Article  PubMed  Google Scholar 

  27. Lou Y, Wang M, Mao W (2012) Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS One 7(5):e37644

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kemal Y, Demirag G, Baş B et al (2015) The value of red blood cell distribution width in endometrial cancer. Clin Chem Lab Med 53:823–827

    Article  CAS  PubMed  Google Scholar 

  29. Koma Y, Onishi A, Matsuoka H et al (2013) Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS One 2013 Nov 11(11):e80240 8(

    Article  CAS  Google Scholar 

  30. Smirne C, Grossi G, Pinato DJ et al (2015) Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma. Dig Liver Dis 47:488–494

    Article  PubMed  Google Scholar 

  31. Qin Y, Wang P, Huang Z et al (2017) The value of red cell distribution width in patients with ovarian cancer. Medicine (Baltimore) 96(17):e6752

    Article  CAS  Google Scholar 

  32. Ichinose J, Murakawa T, Kawashima M et al (2016) Prognostic significance of red cell distribution width in elderly patients undergoing resection for non-small cell lung cancer. J Thorac Dis 8(12):3658–3666

    Article  PubMed  PubMed Central  Google Scholar 

  33. Douglas SW, Adamson JW (1975) The anemia of chronic disorders: studies of marrow regulation and iron metabolism. Blood 45:55–65

    CAS  PubMed  Google Scholar 

  34. Ferrucci L, Guralnik JM, Woodman RC et al (2005) Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 118:1288

    Article  PubMed  Google Scholar 

  35. Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436–444

    Article  CAS  Google Scholar 

  36. Tesarova P, Kvasnicka J (1995) Treatment of anemia in patients with tumors. Cas Lek Cesk 134:647–650

    CAS  PubMed  Google Scholar 

  37. Caro JJ, Salas M, Ward A et al (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91:2214–2221

    Article  CAS  Google Scholar 

  38. Obermair A, Handisurya A, Kaider A et al (1998) The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review. Cancer 83:726–731

    Article  CAS  PubMed  Google Scholar 

  39. Wilairat W, Benjapibal M (2012) Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev 13:3187–3190

    Article  PubMed  Google Scholar 

  40. Banzet S, Sanchez H, Chapot R et al (2012) Interleukin-6 contributes to hepcidin mRNA increase in response to exercise. Cytokine 58(2):158–161

    Article  CAS  PubMed  Google Scholar 

  41. Wu Y, Antony S, Meitzler JL et al (2014) Molecular mechanisms underlying chronic inflammation associated cancers. Cancer Lett 345(2):164–173

    Article  CAS  PubMed  Google Scholar 

  42. Li S, Meng W, Guan Z et al (2016) The hypoxia related signaling pathways of vasculogenic mimicry in tumor treatment. Biomed Pharmacother 80:127–135

    Article  CAS  PubMed  Google Scholar 

  43. Ay S, Eryilmaz MA, Aksoy N et al (2015) Is early detection of colon cancer possible with red blood cell distribution width. Asian Pac J Cancer Prev 753–756

  44. Albayrak S, Zengin K, Tanik S et al (2014) Red cell distribution width as a predictor of prostate cancer progression. Asian Pac J Cancer Prev 15:7781–7784

    Article  PubMed  Google Scholar 

  45. Diem S, Schmid S, Krapf M et al (2017) Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer 111:176–181

    Article  PubMed  Google Scholar 

  46. Bacha S, Sghaier A, Habibech S et al (2017) Combined C-reactive protein and Neutrophil to lymphocyte ratio use predict survival in non-small-cell lung cancer. Tunis Med 95(12):229–235

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Edirne State Hospital, Clinic of Medical Oncology, 22030, Edirne, Turkey

    Yakup Bozkaya

  2. Department of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey

    Bediz Kurt & Fatih Gürler

Authors
  1. Yakup Bozkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bediz Kurt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatih Gürler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yakup Bozkaya.

Ethics declarations

Conflict of interest

All authors report no conflicts of interest relevant to this article.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bozkaya, Y., Kurt, B. & Gürler, F. A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width. Int J Clin Oncol 24, 798–806 (2019). https://doi.org/10.1007/s10147-019-01417-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-019-01417-x

Keywords

Search

Navigation